Home
» EuroPCR Course Programme
View by date
-
View by room
-
|
The 10 most frequently consulted sessions
|
| 1. |
Late breaking trials
Wijns W., Kornowski R.
|
| 2. |
Glimpse into the future: do results of SYNTAX, CARDia and FAME trials impact our practice?
de Bruyne B., Morice M-C., van der Giessen W.J., Wijns W., Pomar J.L., Schultz C.
|
| 3. |
Transcatheter aortic valve implantation registries
Vahanian A., Kolh P.
|
| 4. |
Glimpse into the future: bioabsorbable stents - aiming to restore vascular integrity
de Feyter P., Regar E., Serruys P.W., Schultz C.
|
| 5. |
Forum on bifurcation coronary lesions
Stankovic G., Kornowski R.
|
| 6. |
NEVO™ Sirolimus-eluting coronary stent: first clinical results and future development of RES technology
Serruys P.W.
|
| 7. |
Glimpse into the future: emerging drug-eluting stents
de Feyter P., van der Giessen W.J., Joner M., Schultz C.
|
| 8. |
Shifting the paradigm for oral antiplatelet therapy for acute coronary syndrome patients
Bassand J-P., Meier B.
|
| 9. |
Can we improve patient outcomes with abluminal biodegradable polymer drug-eluting stents? New insights into the LEADERS trial
Morice M-C., Windecker S.
|
| 10. |
Transcatheter aortic valve implantation - what have we learned from the past?
Vahanian A., Walther T.
|
